Published in Tumour Biol on April 04, 2014
Genetic variants of interleukin 17A are functionally associated with increased risk of age-related macular degeneration. Inflammation (2015) 0.81
Role of IL-17A rs2275913 and IL-17F rs763780 polymorphisms in risk of cancer development: an updated meta-analysis. Sci Rep (2016) 0.79
Interleukin-17A gene polymorphism is associated with susceptibility to gastric cancer. Int J Clin Exp Pathol (2015) 0.77
Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy. PLoS One (2015) 0.76
A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen. BMC Cancer (2017) 0.75
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res (2006) 2.76
Ancient local evolution of African mtDNA haplogroups in Tunisian Berber populations. Hum Biol (2010) 1.44
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol (2011) 1.12
Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population. Int J Med Sci (2012) 1.04
Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease? Am J Gastroenterol (2011) 1.03
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2010) 1.01
Scrotal calcinosis: pathogenesis and case report. Acta Dermatovenerol Alp Pannonica Adriat (2005) 1.00
Prognostic value of Pheochromocytoma of the Adrenal Gland Scaled Score (Pass score) tests to separate benign from malignant neoplasms. Tunis Med (2013) 0.99
Mitochondrial DNA structure in North Africa reveals a genetic discontinuity in the Nile Valley. Am J Phys Anthropol (2011) 0.98
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat (2012) 0.98
Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing. J Mol Diagn (2012) 0.97
CHEK2 contribution to hereditary breast cancer in non-BRCA families. Breast Cancer Res (2011) 0.97
Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. Mol Biol Rep (2011) 0.95
Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia. Pathol Oncol Res (2011) 0.92
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene. Int J Cancer (2005) 0.91
Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer. Cancer (2011) 0.91
International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation. Breast Cancer Res Treat (2010) 0.91
Salivary duct carcinoma of the parotid gland. J Oral Maxillofac Pathol (2012) 0.90
Cytokeratin 18 expression pattern correlates with renal cell carcinoma progression: relationship with Snail. Int J Oncol (2010) 0.89
Clinical presentation and outcome of bladder schistosoma-unrelated squamous cell carcinoma: report on 33 consecutive cases. Clin Genitourin Cancer (2007) 0.89
The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer (2011) 0.87
Genetic susceptibility to type 2 diabetes: a global meta-analysis studying the genetic differences in Tunisian populations. Hum Biol (2012) 0.87
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev (2005) 0.86
Testicular synovial sarcoma: a case report. Cancer Biol Med (2012) 0.86
Concern Systemic therapy in the management of metastatic or advanced salivary gland cancers. Head Neck Oncol (2012) 0.86
Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination. Fam Cancer (2008) 0.86
Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients. Cancer Invest (2010) 0.85
Protection of cellular and mitochondrial functions against liver ischemia by N-benzyl-N'-(2-hydroxy-3,4-dimethoxybenzyl)-piperazine (BHDP), a sigma1 ligand. Eur J Pharmacol (2007) 0.84
Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia. J Renin Angiotensin Aldosterone Syst (2009) 0.84
Giant trichoblastoma of the scalp. Tunis Med (2011) 0.84
Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Cancer Genet Cytogenet (2007) 0.84
NY-ESO-1 expression and immunogenicity in prostate cancer patients. Tunis Med (2011) 0.84
Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis. Tumour Biol (2013) 0.83
Genetic structure of Tunisian ethnic groups revealed by paternal lineages. Am J Phys Anthropol (2011) 0.83
HLA class II susceptibility to cervical cancer among Tunisian women. Bull Cancer (2012) 0.83
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer. PLoS One (2012) 0.82
Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genet Cytogenet (2009) 0.82
Sousse, Tunisia: tumultuous history and high Y-STR diversity. Electrophoresis (2012) 0.81
Allele frequencies for 15 autosomal STR markers in the Libyan population. Ann Hum Biol (2011) 0.81
Use of gene expression profiles of peripheral blood lymphocytes to distinguish BRCA1 mutation carriers in high risk breast cancer families. Cancer Inform (2009) 0.81
Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy. Ultrastruct Pathol (2013) 0.81
Primary anorectal melanoma: A case report with extended follow-up. Am J Case Rep (2012) 0.81
46 XY pure gonadal dysgenesis with gonadoblastoma and dysgerminoma. Tunis Med (2008) 0.81
Inflammatory breast cancers in Tunisia and France show similar immunophenotypes. Breast (2007) 0.81
Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population. Cancer Detect Prev (2009) 0.81
Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome. Orphanet J Rare Dis (2013) 0.81
CD99 and HLA-II immunostaining in breast cancer tissue and their correlation with lymph node metastasis. Dis Markers (2013) 0.80
Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population. Fam Cancer (2010) 0.80
Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genet Cytogenet (2009) 0.80
Means of evaluation and protection from doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. J Cancer Res Ther (2014) 0.79
Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Res (2011) 0.79
Combined analysis of smoking, TP53, and FGFR3 mutations in Tunisian patients with invasive and superficial high-grade bladder tumors. Cancer Invest (2009) 0.79
Carcinoma of unknown primary: retrospective study of 437 patients treated at Salah Azaiez Institute. Tunis Med (2013) 0.79
The UMD-APC database, a model of nation-wide knowledge base: update with data from 3,581 variations. Hum Mutat (2014) 0.79
The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population. Ann Hum Biol (2007) 0.79
Systemic therapy in the management of metastatic or advanced salivary gland cancers. Oral Oncol (2012) 0.79
MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage. Asian Pac J Cancer Prev (2011) 0.78
Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors. Bull Cancer (2011) 0.78
A new case of signet ring cell carcinoma of the prostate. Clin Genitourin Cancer (2007) 0.78
3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer. Med Oncol (2014) 0.78
Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia. World J Gastroenterol (2013) 0.78
Association analysis of LCE3C-LCE3B deletion in Tunisian psoriatic population. Arch Dermatol Res (2012) 0.78
Protozoan parasite aquaporins. Expert Rev Proteomics (2009) 0.78
KRAS mutations in colorectal cancer from Tunisia: relationships with clinicopathologic variables and data on TP53 mutations and microsatellite instability. Mol Biol Rep (2013) 0.77
Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis. J Clin Neurosci (2012) 0.77
Lynch syndrome in Tunisia: first description of clinical features and germline mutations. Int J Colorectal Dis (2011) 0.77
Nijmegen breakage syndrome gene (NBS1) is not the tumor suppressor gene at 8q21.3 involved in colorectal carcinoma. Oncol Rep (2002) 0.77
Correlation of peroxisome proliferator-activated receptor (PPAR-γ) mRNA expression with Pro12Ala polymorphism in obesity. Biochem Genet (2013) 0.77
Aurora A overexpression and pVHL reduced expression are correlated with a bad kidney cancer prognosis. Dis Markers (2012) 0.77
[Retiform Sertoli-Leydig tumor with heterologous mucinous differentiation]. Tunis Med (2012) 0.77
Somatic mutation of MutYH in Tunisian patients with sporadic colorectal cancer. J Clin Lab Anal (2007) 0.77
Substructure of a Tunisian Berber population as inferred from 15 autosomal short tandem repeat loci. Hum Biol (2008) 0.77
The G1057D polymorphism of IRS-2 gene is not associated with type 2 diabetes and obese patients among ethnic groups in Tunisian population. Clin Biochem (2009) 0.77
Dietary intakes of essential nutrients among Arab and Berber ethnic groups on rural Tunisian island. Nutrition (2010) 0.77